News
By Jacob Gronholt-Pedersen (Reuters) -Shares in Novo Nordisk fell as much as 6% on Friday before recovering some ground later ...
14h
MedPage Today on MSNJustin Timberlake's Diagnosis; Senate Defies Trump on NIH; CMS' Wegovy Coverage Plan
Note that some links may require registration or subscription. Justin Timberlake said he has been diagnosed with Lyme disease ...
Heston Blumenthal has revealed that he is taking the weight-loss drug Wegovy. The celebrity chef admitted his use of the drug ...
Weight loss medications like Wegovy can be life-changing for people living with obesity or excess weight with related health ...
Heston Blumenthal has revealed he's taking the weight-loss drug Wegovy. In a new interview, the celebrity chef, 59, told how ...
A study analyzing 92,000 people found semaglutides, found in GLP-1 drugs such as Ozempic and Wegovy, were linked to a 33% ...
Some of the most recognizable brand names that could be impacted by new tariffs include Ozempic and Wegovy, two injectable ...
Shares of Novo Nordisk (NYSE: NVO) are falling this week, down 33% as of 3:27 p.m. ET on Friday. The drop comes as the S&P ...
The chef said he is taking Wegovy to combat the effects of his bipolar medication, which he said has caused him to put on ...
16h
Free Malaysia Today on MSNNovo Nordisk’s shares extend losses, erasing nearly all gains since Wegovy launch
Novo Nordisk on Tuesday slashed its forecast for 2025 sales growth due to competition from compounded, or copycat, versions ...
The Washington Post reported the CMS is considering a plan that could allow Medicare plans to pay for the drugs.
Medicare and Medicaid could expand coverage of GLP-1 drugs, such as Ozempic and Wegovy, and pay for patients’ use of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results